| |
Subscribe
The Golden State BioBusiness News™ is available to qualified subscribers for no charge. Published ten times a year, BioBusiness News provides highly relevant strategic and operational information that helps our readers build and manage successful life science companies. With your free subscription, you will get:
- Spotlight Company - interviews with CEOs of emerging biotechnology and medical device companies including Novocell and Athenagen
- Opinion and Commentary - industry insiders express their opinions on the state of the industry
- Money Talks - financial experts tell you how to stretch your investment dollars
- Legal Tips - how to deal with IP, regulatory and other legal issues
- Risk and Reward - the ins and outs of insurance and benefits for the growing biotech and device company
- Real Estate - advice on selecting, negotiating and managing this key corporate asset
- Company News - updates on the latest happenings in California biomedical companies
- Deal Diary - recent financing and M&A activities
- Events Calendar - upcoming investment and business conferences in and near California
Free to Qualified Subscribers
If you are a senior executive (e.g., CEO, CSO, CFO, VP, etc.) of a California biotechnology, medical device, instrumentation, services or investment firm in the life sciences industry, please complete an online Subscription Application. We will evaluate your application and qualified subscribers will receive their first issue in approximately two to six weeks.
If you do not qualify for the complimentary industry subscription, you may receive The Golden State BioBusiness News™ for $250/year. Please send your name, title, company, address, phone and email information and your check to: Subscriptions, Golden State BioBusiness News, 400 S. El Camino Real, Suite 1200, San Mateo, CA 9402. Or contact us with any questions.
Last Updated: Oct 3, 2006 at 12:36 PM
|
|